Home » Topics » BioWorld Science

BioWorld Science
RSS

Long, low growth factor signaling promotes healing

Nov. 12, 2019

LRG as a novel biomarker to monitor the efficacy of adalimumab treatment in UC and CD

Nov. 12, 2019

Getting ncAAs ready for playoffs

Nov. 12, 2019

Oncogene-linked prodrug strategy for selective KEAP1 mutant NSCLC cytotoxicity

Nov. 11, 2019

Roche announces discontinuation of RG-6206 development in DMD

Nov. 11, 2019

Lyvgen initiates first-in-human study of LVGN-6051 in advanced or metastatic malignancy

Nov. 11, 2019

New phase IIa study investigates use of MTPS-9579A in asthma

Nov. 11, 2019

First-in-human comparison of LY-2775240 and apremilast in healthy volunteers

Nov. 11, 2019

FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions

Nov. 11, 2019

SUNFISH study of risdiplam in type 2 and 3 SMA meets primary endpoint

Nov. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...